Wong BJ. Sensory nerves and nitric oxide contribute to reflex cutaneous vasodilation in humans. Am J Physiol Regul Integr Comp Physiol 304: R651-R656, 2013. First published February 13, 2013 doi:10.1152/ajpregu.00464.2012.-We tested the hypothesis that inhibition of cutaneous sensory nerves would attenuate reflex cutaneous vasodilation in response to an increase in core temperature. Nine subjects were equipped with four microdialysis fibers on the forearm. Two sites were treated with topical anesthetic EMLA cream for 120 min. Sensory nerve inhibition was verified by lack of sensation to a pinprick. Microdialysis fibers were randomly assigned as 1) lactated Ringer (control); 2) 10 mM nitro-L-arginine methyl ester (L-NAME) to inhibit nitric oxide synthase; 3) EMLA ϩ lactated Ringer; and 4) EMLA ϩ L-NAME. Laser-Doppler flowmetry was used as an index of skin blood flow, and blood pressure was measured via brachial auscultation. Subjects wore a water-perfused suit, and oral temperature was monitored as an index of core temperature. The suit was perfused with 50°C water to initiate whole body heat stress to raise oral temperature 0.8°C above baseline. Cutaneous vascular conductance (CVC) was calculated and normalized to maximal vasodilation (%CVCmax). There was no difference in CVC between control and EMLA sites (67 Ϯ 5 vs. 69 Ϯ 6% CVCmax), but the onset of vasodilation was delayed at EMLA compared with control sites. The L-NAME site was significantly attenuated compared with control and EMLA sites (45 Ϯ 5% CVCmax; P Ͻ 0.01). Combined EMLA ϩ L-NAME site (25 Ϯ 6% CVCmax) was attenuated compared with control and EMLA (P Ͻ 0.001) and L-NAME only (P Ͻ 0.01). These data suggest cutaneous sensory nerves contribute to reflex cutaneous vasodilation during the early, but not latter, stages of heat stress, and full expression of reflex cutaneous vasodilation requires functional sensory nerves and NOS. skin blood flow; hyperthermia; nitric oxide; microdialysis INCREASES IN SKIN BLOOD FLOW and sweating represent humans' primary physiological defense against an increase in core temperature. The initial increase in skin blood flow during hyperthermia is driven primarily by withdrawal of tonic sympathetic vasoconstrictor tone, which results in approximate doubling of skin blood flow (8, 25) . At a critical core temperature threshold, further increases in skin blood flow and the onset of sweating are mediated by reflex sympathetic cholinergic nerve activity (8). This reflex cutaneous active vasodilation accounts for 85-95% of the increase in skin blood flow during hyperthermia and can result in nearly 8 l/min of cardiac output directed to the cutaneous vasculature (26).
INCREASES IN SKIN BLOOD FLOW and sweating represent humans' primary physiological defense against an increase in core temperature. The initial increase in skin blood flow during hyperthermia is driven primarily by withdrawal of tonic sympathetic vasoconstrictor tone, which results in approximate doubling of skin blood flow (8, 25) . At a critical core temperature threshold, further increases in skin blood flow and the onset of sweating are mediated by reflex sympathetic cholinergic nerve activity (8) . This reflex cutaneous active vasodilation accounts for 85-95% of the increase in skin blood flow during hyperthermia and can result in nearly 8 l/min of cardiac output directed to the cutaneous vasculature (26) .
The cotransmission theory of cutaneous active vasodilation suggests acetylcholine and one or more unknown vasodilators are coreleased from sympathetic cholinergic nerves, where acetylcholine is primarily responsible for the sweat response and the unknown vasodilator(s) are responsible for the reflex cutaneous vasodilation (17, 25) . The precise vasodilator(s) released from sympathetic cholinergic nerves remains unresolved; however, several vasodilators have been implicated in reflex cutaneous vasodilatation, including vasoactive intestinal polypeptide (1, 18) , vasodilator prostanoids (21) , H1 histamine receptors (32) , neurokinin-1 (NK 1 ) receptors (30) , and transient receptor potential vanilloid type 1 (TRPV-1) channels (28) .
To date, the contribution of cutaneous sensory nerves to reflex cutaneous vasodilation has been thought to be minimal, if at all, and the data suggesting a role for sensory nerves remains equivocal. Charkoudian et al. (3) demonstrated that chronic capsaicin treatment of the skin attenuated the skin blood flow response to whole body heat stress, suggesting no contribution of capsaicin-sensitive afferent sensory nerves to reflex cutaneous vasodilation. The data from Charkoudian et al. (3) provide indirect evidence against a role for cutaneous sensory nerves as chronic capsaicin depletes sensory nerve terminals of substance P and calcitonin gene-related peptide. Chronic capsaicin may not inhibit TRPV-1 channels or deplete other cotransmitters and therefore may not completely inhibit sensory nerve function.
In contrast to the study by Charkoudian et al. (3) , our laboratory has shown that both NK 1 activation, (30) and presumably substance P, and TRPV-1 channels (28) contribute to reflex cutaneous vasodilation.Our laboratory has also shown that vasodilation elicited by both NK 1 receptor and TRPV-1 channel activation during whole body heat stress includes a significant nitric oxide (NO) component, suggesting a sensory nerve-NO interaction. Taken together, the data from our laboratory provide evidence, albeit indirect, of a potential role for cutaneous sensory nerves to reflex cutaneous vasodilation in humans. These previous data further suggest that if sensory nerves are indeed involved in reflex cutaneous vasodilation, a portion of the sensory nerve component may be due to NO. The purpose of this study was to directly investigate whether cutaneous sensory nerves directly contribute to reflex cutaneous vasodilation and whether any sensory nerve component is due to NO. We tested the hypothesis that inhibition of sensory nerve transduction would attenuate reflex cutaneous vasodilation and combined sensory nerve inhibition, and NO synthase (NOS) inhibition would attenuate reflex cutaneous vasodilation to a greater extent than sensory nerve inhibition of NOS inhibition alone.
METHODS
Ethical approval. The Institutional Review Board at Kansas State University approved all protocols for this study. Verbal and written informed consent were obtained from each subject before participation in the study, and all protocols conformed to the guidelines as set forth by the Declaration of Helsinki.
Subjects. Nine subjects (6 men, 3 women; ages 22-27 yr) participated in this study. All subjects were healthy, nonobese, nonsmokers, had no history of cardiovascular or metabolic diseases, and were not taking any medications except for two female subjects who were taking oral contraceptives. Although female sex hormones are known to alter the skin blood flow response to whole body heating (4, 5, 14) , phase of menstrual cycle or oral contraceptive use was noted but not controlled for in these experiments.
Instrumentation. Subjects were equipped with four microdialysis fibers on the ventral aspect of the left forearm. Microdialysis fibers were placed in the absence of anesthesia; however, ice was used to numb the skin before placement (9) . Microdialysis fibers were placed by first placing a 23-gauge needle in the dermal layer of the skin. The fiber was then threaded through the lumen of the needle, the needle was removed from the skin, and the semipermeable membrane of the fiber was left in the skin. The semipermeable membranes of the fibers were 10 mm in length with a 55-kDa molecular mass cutoff (CMA 31 Linear Probe; CMA Microdialysis; Kista, Sweden). Placement of microdialysis fibers results in a minor trauma hyperemia that was allowed to subside before commencement of the experimental protocol (ϳ45-90 min). Each microdialysis fiber was perfused with lactated Ringer solution during the trauma resolution period.
After placement of the microdialysis fibers, two sites were treated with the topical anesthetic EMLA cream (AstraZeneca, Wilmington, DE; 2.5% lidocaine and 2.5% prilocaine). The EMLA cream (ϳ2.5 g) was applied to an area of skin ϳ4 cm 2 directly over the membrane of two of the microdialysis fibers, and an occlusive dressing was placed over the top of the sites. An initial application of EMLA cream was applied for 90 min after which the cream was wiped off and a second application was applied to the same sites under an occlusive dressing for an additional 30 min. Thus EMLA cream was applied to the skin for a total of 2 h, and efficacy of sensory nerve inhibition was verified via lack of sensation to a pinprick and scratching/pinching of the skin (10, 20, 22) . Lack of sensation to pin prick and scratching of the skin was also confirmed at the end of the experiment.
Subjects' blood pressure was measured via automated brachial auscultation every 5 min and verified via manual brachial auscultation, and subjects' heart rate was recorded from a 3-lead electrocardiogram (S/5 Light Monitor; Datex-Ohmeda, GE Healthcare; Madison, WI).
Red blood cell flux measured via laser-Doppler flowmetry (PeriFlux 5010 laser-Doppler perfusion monitor; Perimed; Jarfalla, Sweden) was used to provide an index of skin blood flow, and local heating units (PF5020 local heating units and PeriFlux 5020 Temperature Unit; Perimed) were placed on the skin directly over each microdialysis membrane. An integrated laser-Doppler probe (Probe 413; Perimed) was placed in the center of each local heating unit to measure red blood cell flux directly over each microdialysis site. The temperature of the local heaters at each of the microdialysis sites was clamped at 33°C during baseline and for the duration of the whole body heating period; the temperature was increased to 43°C at the end of the whole body heating period to elicit maximal cutaneous vasodilation (see below).
Subjects wore a water-perfused suit (Allen Vanguard; Ottawa, ON, Canada), which covered the entire body except the head, hands, feet, and experimental forearm, to control whole body temperature. Oral temperature was measured by placing a thermistor in the sublingual sulcus and used as an index of core temperature. Subjects' oral temperature was monitored for 5-10 min before, during, and for at least 20 min upon completion of the whole body heating period.
Experimental protocol. Baseline skin blood flow, blood pressure, and oral temperature data were collected for 5-10 min following the trauma resolution period during which time thermoneutral water was pumped through the water-perfused suit. Drug infusion through each microdialysis fiber commenced following baseline measurements. The two sites with intact sensory nerve function were randomly assigned as either: 1) control (lactated Ringer) or 2) NO synthase (NOS) inibition via 10 mM nitro-L-arginine methyl ester (L-NAME; Tocris Biosciences; Ellisville, MO). Similarly, the two sites with sensory nerve inhibition were randomly assigned as either: 1) control (lactated Ringer), or 2) NOS inhibition via 10 mM L-NAME.
We, and others, have previously shown a 10 mM concentration of L-NAME adequately inhibits NOS in human skin (6, 7, 11, 20, 21, (27) (28) (29) , and this duration of EMLA cream inhibits sensory nerve function (10, 21, 22) . All drug treatments were dissolved in lactated Ringer (Baxter Healthcare; Deerfield, IL) and were perfused at a constant rate of 2 l/min with a microinfusion pump (Bee Hive controller and Baby Bee Syringe Pumps; Bioanalytical Systems, West Lafayette, IN). L-NAME was infused for at least 45 min before commencement of whole body heating.
To initiate whole body heating, subjects were covered with a plastic water-impermeable rain suit to minimize evaporative heat loss, and 50°C water was circulated through the water-perfused suit. Whole body heating continued until subjects' oral temperature was raised at least 0.8°C above baseline (time range: 35-50 min) after which subjects' temperature was maintained at this level to acquire a stable 10-min plateau in skin blood flow. Once a plateau in skin blood flow was achieved, subjects were cooled by pumping 33°C water through the suit and removing the plastic rain suit. Maximal cutaneous vasodilation was elicited via infusion of sodium nitroprusside (SNP) at a rate of 2 l/min and increasing the temperature of the local heating units to 43°C. This temperature increase and dose of SNP have been previously determined effective in eliciting a maximal skin blood flow response (6, 7, 11, (27) (28) (29) .
Data collection and analysis. Data were digitized and stored at 100 Hz on a personal computer and were analyzed offline using signalprocessing software (Windaq; Dataq Instruments, Akron, OH). Systemic arterial pressure was recorded from the automated brachial auscultation measurements and verified by calculating diastolic blood pressure plus one-third pulse pressure from the manual brachial auscultation measurements. Cutaneous vascular conductance (CVC) was calculated as red blood cell flux divided by systemic arterial pressure and normalized to maximal vasodilation (%CVC max) via SNP infusion and local heating to 43°C. The percent contribution of sensory nerves and NO were calculated using the following equation:
where %CVC max Treatment is the %CVCmax value at EMLA, L-NAME, or combined EMLA ϩ L-NAME sites.
A stable 3-to 5-min period of skin blood flow was used for analysis of baseline, whole body heating plateau, and maximal skin blood flow. To determine the magnitude of increase in %CVC max for a given increase in oral temperature (⌬Tor), skin blood flow during the final minute of each 0.1°C increase in oral temperature from baseline (⌬Tor 0.0°C) to the end of heat stress (⌬Tor 0.8°C) was used for analysis.
The sensitivity (slope) of the response at control and EMLA sites was determined via regression analysis of the line relating %CVCmax as a function of increasing Tor. Slopes were calculated for the steep/rapid portion of each curve; baseline and the plateau during whole body heating were excluded (3, 5) .
A one-way repeated measures ANOVA was used to compare: 1) the effect of drug treatment between experimental sites; 2) the effect of drug treatment on the increase in %CVC max during hyperthermia; and 3) the percent contribution of sensory nerves and NO to reflex cutaneous vasodilation. The slopes of the lines for the control and EMLA sites were compared using a paired t-test. A two-way ANOVA with repeated measures was used to compare the effect of drug treatment on the increase in %CVC max for each 0.1°C increase in oral temperature (drug treatment ϫ %CVCmax ϫ ⌬Tor). For all ANOVAs, when a significant F value was observed, Tukey's post hoc analysis was used to determine where significant differences occurred. All statistical analyses were performed using SigmaStat 3.5 (Systat Software; Point Richmond, CA), and P values Ͻ 0.05 were considered to be significant. All data presented are means Ϯ SE.
RESULTS
There was no effect of drug administration on baseline CVC between experimental sites. Baseline CVC averaged 14 Ϯ 3%CVC max at control sites, 14 Ϯ 5%CVC max at EMLA sites, 15 Ϯ 2%CVC max at L-NAME sites, and 12 Ϯ 4%CVC max at EMLA ϩ L-NAME sites. Figure 1 shows the increase in CVC in response to a 0.8°C increase in oral temperature at all treatment sites. There was no difference in CVC between control (67 Ϯ 5%CVC max ) and EMLA sites (69 Ϯ 6%CVC max ). The CVC at L-NAME (45 Ϯ 5%CVC max ) and combined EMLA ϩ L-NAME (25 Ϯ 6%CVC max ) sites were significantly attenuated compared with both control and EMLA sites (P Ͻ 0.01 for both conditions).
The CVC at EMLA ϩ L-NAME sites was also attenuated compared with L-NAME sites (P Ͻ 0.01). Figure 2 shows the CVC response at all treatment sites as a function of increasing oral temperature. There was a significant increase in CVC at control sites following a 0.2°C increase in oral temperature that persisted throughout the period of whole body heating. The increase in CVC was shifted to higher oral temperatures at all treatment sites (L-NAME: 0.4°C, EMLA: 0.5°C, EMLA ϩ L-NAME: 0.6°C) compared with control (P Ͻ 0.05 for all conditions). The sensitivity (slope) of the increase in CVC was significantly greater for EMLA sites (216 Ϯ 122%CVC max /°C) compared with control sites (114 Ϯ 48%CVC max /°C; P Ͻ 0.05). Figure 3 shows the percent contribution of sensory nerves, NO, and combined sensory nerves ϩ NO. Sensory nerves contributed 2 Ϯ 2%, NO contributed 39 Ϯ 4%, and combined sensory nerves ϩ NO contributed 78 Ϯ 5% to the increase in CVC in response to a 0.8°C increase in oral temperature.
DISCUSSION
There are three major findings from the present investigation. First, it appears that cutaneous sensory nerves are important for the initial increase in skin blood flow during mild heat stress stages of heat stress. This conclusion is based on the rightward shift in the oral temperature at which CVC significantly increased above baseline EMLA compared with control sites (Fig. 2) . Second, sensory nerves do not appear to independently contribute to reflex cutaneous vasodilation during the latter stages of heat stress. This conclusion is based on the observation that the magnitude of the increase in CVC during heat stress was unaffected by cutaneous sensory nerve inhibition with EMLA cream compared with control sites (Figs. 1 and 2) . Third, the present data suggest a role for cutaneous sensory nerves is unmasked via inhibition of NOS and cutaneous sensory nerves, and NO are required for full expression of reflex cutaneous vasodilation in humans (Figs. 1 and 3) . Data from our laboratory has shown that both NK 1 receptors and TRPV-1 channels contribute to reflex cutaneous vasodilation in humans. The NK 1 receptors preferentially bind substance P (23), a neuropeptide located primarily in cutaneous sensory nerve terminals, and TRPV-1 channels are putative ion channels of cutaneous sensory nerves that are activated by heat and capsaicin, the active ingredient in hot chili peppers (2) . Taken together, these previous observations suggest cutaneous sensory nerves may contribute to reflex cutaneous vasodilation.
In this study, we demonstrated that sensory nerve activation is important for the increase in CVC during the early stages of heat stress, but sensory nerves do not appear to contribute to the latter stages of reflex cutaneous vasodilation. The lack of an effect of sensory nerve inhibition during the latter stages of heat stress is discordant with our previous NK 1 receptor and TRPV-1 channel data. A possible explanation for these discordant findings is that during the early stages of heat stress, increases in skin and/or blood temperature activate sensory nerves and the early increase in CVC may be due to a local sensory nerve response, whereas during the latter stages of heat stress the increase in CVC is mediated by local (endothelial) and autonomic (sympathetic cholinergic) mechanisms. An additional explanation may be due to NK 1 receptor and TRPV-1 channel activation arising from sources other than cutaneous sensory nerves. Previous data in other vascular beds have shown both NK 1 receptors and TRPV-1 channels are located in endothelial cells and interact with NO (16, 19, 24, 31, 33, 34) , and this would be consistent with our previous data showing an interaction between NK 1 receptors and NO (30) and TRPV-1 channels and NO (28) in human skin during hyperthermia and the lack of an effect of sensory nerve inhibition in the present study.
The data from the present study showing no effect of sensory nerve inhibition on the magnitude of increase in CVC during the latter stages of heat stress are in accord with previous data from Charkoudian et al. (3) who investigated a potential role for cutaneous sensory nerves by using chronic capsaicin cream and found no effect on the CVC response to whole body heating. These authors thus concluded capsaicin-sensitive cutaneous afferent nerves did not contribute to reflex cutaneous vasodilation. In the study by Charkoudian and colleagues (3), there was no shift in the threshold for reflex cutaneous vasodilation and no change in the sensitivity of the response between control and capsaicin-treated sites. Conversely, we observed a rightward shift (i.e., shift to a higher oral temperature) in EMLA-treated sites and an increase in the sensitivity (slope) of the response in EMLA sites. The reasons for the discordant findings for the threshold and sensitivity between the present data and those of Charkoudian et al. are unclear but may be due to differences in means by which sensory nerve function was inhibited. While both EMLA and capsaicin cream inhibit sensory nerve function, it is likely the mechanisms by which EMLA and capsaicin do this may result in differential effects. Nevertheless, the data from the present study appear to suggest that cutaneous sensory nerves are important for the early increase in cutaneous vascular conductance during heat stress.
An interesting finding from the present study was that combined sensory nerve inhibition and NOS inhibition (EMLA ϩ L-NAME sites) attenuated reflex cutaneous vasodilation by ϳ80% (Figs. 1-3 ), which suggests both sensory nerve function and NO are required for full expression of reflex cutaneous vasodilation. In addition, these data suggest a role for cutaneous sensory nerves can be unmasked when NOS is inhibited. A mechanistic link between sensory nerve function and NO has been shown where NO can stimulate the release of neuropeptides, in particular calcitonin gene-related peptide, from afferent sensory nerves (12, 13, 15) . It is possible that when sensory nerve function is inhibited, but NO is present, the majority of cutaneous vasodilation is mediated by NO and other vasodilator pathways; however, when both sensory nerve function and NOS are inhibited, the remaining vasodilator pathways are unable to fully vasodilate the cutaneous microvasculature during heat stress. A substantial attenuation in reflex cutaneous vasodilation, similar in magnitude to that observed in the present study, has been observed in other studies by McCord and colleagues (21) and Wong and Minson (30) and, in all cases, the robust attenuation was in sites where NOS was inhibited. Taken together, these data further support the direct and synergistic role of NO in reflex cutaneous vasodilation as proposed by Wilkins et al. (27) . The specifics of this potential interaction between sensory nerves and NO warrants further study.
Limitations. It is possible inhibition of sensory nerve function with EMLA cream not only affected the cutaneous afferent sensory nerves but also the sympathetic cholinergic active vasodilator nerve fibers. There are at least two lines of evidence that argue against this possibility. First, the magnitude of the increase in CVC during whole body heating was unaffected by EMLA cream and reached levels similar to that achieved in control sites. Second, in three subjects, we performed whole body cold stress and observed similar decreases in skin blood flow and CVC at control and EMLA-treated sites (data not shown). Although whole body cold stress activates sympathetic adrenergic vasoconstrictor nerves, this data suggests EMLA cream preferentially inhibits sensory nerves while leaving autonomic nerve function intact. A second limitation to our study is the use of oral temperature as an index of core body temperature. This method of measuring body temperature can be variable and can be influenced by ambient air temperature (breathing through the mouth; talking) and by placement in the sublingual sulcus and the accuracy may not be as reliable as telemetric pill, rectal temperature, or esophageal temperature. All subjects were instructed to keep the thermistor in the same location throughout the study and to not speak or breath through their mouth. While our method of temperature measurement does have limitations, we do not feel these limitations significantly influence our data or interpretation of the data.
Perspectives and Significance
The data from the present study suggest cutaneous sensory nerves are important for the initial increase in skin blood flow during mild hyperthermia (i.e., increase in oral temperature of up to ϳ0.5°C). This increase in core temperature frequently occurs in athletes and military personnel and other individuals performing tasks in warm environments. These data are also important for individuals susceptible to heat-related illnesses and in individuals with sensory nerve deficits. For example, diabetics with sensory neuropathy may not be able to adequately increase skin blood flow during mild heat stress, which would make these individuals more susceptible to heat-related illness or even death during mild heat stress. Furthermore, individuals with compromised sensory nerve function and reduced bioavailable NO (e.g., aging, diabetes) may not be able to effectively regulate core temperature during mild or severe heat stress. Thus our current data have important implications for human thermoregulation in both health and disease across a wide range of hyperthermic conditions.
